Results 41 to 50 of about 10,740,045 (356)

American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5

open access: yesArthritis & Rheumatology, 2022
To provide guidance to rheumatology providers on the use of COVID‐19 vaccines for patients with rheumatic and musculoskeletal diseases (RMDs).
J. Curtis   +13 more
semanticscholar   +1 more source

Role of raloxifene in the management of postmenopausal osteoporosis of rheumatoid arthritis patients

open access: yesEuropean Pharmaceutical Journal, 2023
Due to the severe side effects of long-term treatment using hormone replacement therapy, Raloxifene (RLX) is introduced with beneficial effects on rheumatoid arthritis (RA) for postmenopausal women.
Salari M.   +3 more
doaj   +1 more source

Estimating the burden of rheumatoid arthritis in Africa:A systematic analysis [PDF]

open access: yes, 2012
Rheumatoid arthritis (RA) has an estimated worldwide prevalence of 1%. It is one of the leading causes of chronic morbidity in the developed world, but little is known about the disease burden in Africa. RA is often seen as a minor health problem and has
Abdel-Nasser   +32 more
core   +3 more sources

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

open access: yesAnnals of the Rheumatic Diseases, 2019
To update the European League Against Rheumatism (EULAR) recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) published in 2011.
V. Furer   +20 more
semanticscholar   +1 more source

c-Jun N-Terminal Kinase in Inflammation and Rheumatic Diseases. [PDF]

open access: yes, 2012
The c-Jun N-terminal kinases (JNKs) are members of the mitogen-activated protein kinase (MAPK) family and are activated by environmental stress. JNK is also activated by proinflammatory cytokines, such as TNF and IL-1, and Toll-like receptor ligands ...
Firestein, Gary S, Guma, Monica
core   +1 more source

2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

open access: yesAnnals of the Rheumatic Diseases, 2022
Background Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring.
A. de Thurah   +29 more
semanticscholar   +1 more source

Group education for rheumatoid arthritis patients [PDF]

open access: yes, 1997
This article reviews the effectiveness of group education programs in improving the knowledge, behavior, and health status of patients with rheumatoid arthritis (RA) and evaluates to what extent various programs fulfill certain criteria for educational ...
Rasker, Johannes J.   +2 more
core   +8 more sources

Vitamin E and Autoimmune Diseases: A Narrative Review [PDF]

open access: yesReviews in Clinical Medicine, 2018
Autoimmune diseases are characterized by the attack of the immune system to normal tissues. Patients with autoimmune diseases usually have the deficiency of dietary factors  that may be related to the etiology of these conditions.
Zahra Rezaieyazdi   +3 more
doaj   +1 more source

Placental Morphology of Pregnant Iraqi Women with Rheumatic Heart Disease [PDF]

open access: yes, 2016
Background: Placental morphology and cellular arrangement can be altered in maternal diseases. Rheumatic heart disease (RHD) is a chronic heart condition that can lead to death in pregnant women.
Al-Ani, I. M. (Imad)   +5 more
core   +3 more sources

Sustained Drug Free Remission of Lupus Panniculitis with Methotrexate: A Report From Nepal

open access: yesJournal of Nepal Medical Association, 2018
Cutaneous manifestations are second most common presenting feature of lupus. Discoid lupus erythematosus is the most common variant amongst all; lupus panniculitis being described in only 2-5% of cases.
Binit Vaidya   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy